CRISPR-Cas guides the future of genetic engineering
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution. RNA-guided Cas enzymes have been adopted as tools to manipulate the genomes of cultured cells, animals, and plants, accelerating the pace of fundamental research and enabling clinical and agricultural breakthroughs. We describe the basic mechanisms that set the CRISPR-Cas toolkit apart from other programmable gene-editing technologies, highlighting the diverse and naturally evolved systems now functionalized as biotechnologies. We discuss the rapidly evolving landscape of CRISPR-Cas applications, from gene editing to transcriptional regulation, imaging, and diagnostics. Continuing functional dissection and an expanding landscape of applications position CRISPR-Cas tools at the cutting edge of nucleic acid manipulation that is rewriting biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas9 and related enzymes have been used to manipulate the genomes of cultured cells, animals and plants, vastly accelerating the pace of fundamental research and enabling breakthroughs in agriculture and synthetic biology (reviewed in refs. 6-9).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Cited by
Items 701–800 of 1,000
Applications of CRISPR technology in cellular immunotherapy
Zhou, X., Renauer, P. A., Zhou, L., Fang, S., & Chen, S. (2023) · Immunological Reviews · doi:10.1111/imr.13241 · Cited by 14
“8 In the gene editing process, Cas9 or Cas12a is guided to specific gene loci by sgRNAs to induce double-stranded DNA breaks (DSBs), which can be repaired through error-prone nonhomologous end joining (NHEJ) or homology-directed repair (HDR).”
BackgroundMetal or muscle? The future of biologically inspired robots
Trimmer, B. A. (2020) · Science Robotics · doi:10.1126/scirobotics.aba6149 · Cited by 14
A framework for parsing heritable information
Jose, A. M. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0154 · Cited by 15
“Our current ability to exquisitely edit genomes and transcriptomes [39,40] is a limited manipulation of living systems in that the outcome of the edit is entirely determined by how the living system interprets the change.”
BackgroundTM2D genes regulate Notch signaling and neuronal function in Drosophila
Salazar, J. L., Yang, S.-A., Lin, Y. Q., Li-Kroeger, D., Marcogliese, P. C., Deal, S. L., Neely, G. G., & Yamamoto, S. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009962 · Cited by 13
“Since Df(1)FF8 has not been molecularly characterized and it was uncertain whether all of the phenotypes attributed to amx are due to loss of amx alone, we decided to generate a clean null allele of amx (hereafter referred to as amx) using CRISPR/Cas9 technology [31,32] (Fig 1).”
MethodHegeman, C. V., Elsharkasy, O. M., Driedonks, T. A. P., Friesen, K., Vader, P., & de Jong, O. G. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113853 · Cited by 13
Gene‐targeted therapies: Overview and implications
Brooks, P. J., Urv, T. K., & Parisi, M. A. (2023) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.32033 · Cited by 15
“In the CRISPR-Cas9 system (Knott & Doudna, 2018), the Cas9 nuclease is targeted within the genome using guide RNAs.”
BackgroundCRISPER/CAS: A POTENTIAL TOOL FOR GENOMES EDITING
Rauf, S., Shahid, A., Faizan, M., & Amjad3, M. N. K. A. I. (2023) · Agrobiological Records · doi:10.47278/journal.abr/2023.044 · Cited by 17
Paleologo, M., Lanubile, A., Leggieri, M. C., Graffigna, G., Gomarasca, P., & Barello, S. (2024) · Public Understanding of Science · doi:10.1177/09636625241254981 · Cited by 12
“…latter involves the use of site-directed nucleases like zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and the most advanced clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 (CRISPR/Cas9; Knott and Doudna, 2018).”
BackgroundYou, D. H., Xu, T., Huang, B.-Z., Wu, F., Deng, L., Liu, Z.-Y., Ge, L., Liu, Z., Sun, J. M., Zeng, X., et al. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342918 · Cited by 13
The future of complement therapeutics
Kolev, M. V., Rao, K. N., Yeh, M. W., Parikh, A., & Deschatelets, P. (2024) · Exploration of Immunology · doi:10.37349/ei.2024.00161 · Cited by 15
Hayat, U., Cao, K., Wang, L., Zhu, G., Fang, W., Wang, X., Chen, C., Li, Y., & Wu, J. (2025) · Plants · doi:10.3390/plants14020175 · Cited by 13
Engineering adeno-associated viral vectors for CRISPR/Cas based in vivo therapeutic genome editing
Moyo, B., Brown, L. B. C., Khondaker, I., & Bao, G. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123314 · Cited by 13
Schwardmann, L. S., Nölle, V., & Elleuche, S. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10459-5 · Cited by 13
“Both, the nucleases’ in and ex vivo usage for gene disruption, addition and correction pave the way to more personalized therapies as in the treatment of HIVor cancer (Knott and Doudna 2018; Pan et al. 2013; Saha et al. 2019).”
BackgroundSequential Activation of Guide RNAs to Enable Successive CRISPR-Cas9 Activities
Clarke, R., Terry, A. R., Pennington, H., Hasty, C., MacDougall, M. S., Regan, M. R., & Merrill, B. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.12.003 · Cited by 13
CRISPRing protozoan parasites to better understand the biology of diseases
Kirti, A., Sharma, M. D., Rani, K., & Bansal, A. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.004 · Cited by 13
DNA methylation–independent long-term epigenetic silencing with dCRISPR/Cas9 fusion proteins
Ding, L., Schmitt, L. T., Brux, M., Sürün, D., Augsburg, M., Lansing, F., Mircetic, J., Theis, M., & Buchholz, F. (2022) · Life Science Alliance · doi:10.26508/lsa.202101321 · Cited by 19
“Initially, Cas9 has been programmed with short guide RNAs (sgRNAs) to introduce DNA double strand breaks at specific genomic target sites to generate deletions or insertions through host cell DNA repair systems (Knott & Doudna, 2018).”
BackgroundReprogramming Microbial CO2-Metabolizing Chassis With CRISPR-Cas Systems
Yu, H., Wang, S., & Xia, P. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.897204 · Cited by 14
“CRISPR-Cas-based genome editing in microbes typically has two steps: RNA-guided DNA cleavage and DNA repair of the doublestrand break, the latter of which eventually resulted in the editing of a target gene (Selle and Barrangou, 2015; Knott and Doudna, 2018).”
BackgroundYi, S., Kim, S., Vincent, M. P., Yuk, S. A., Bobbala, S. K. R., Du, F., & Scott, E. A. (2022) · iScience · doi:10.1016/j.isci.2022.104555 · Cited by 13
“Plasmid DNA (pDNA) transfection is advantageous for gene therapies requiring larger genetic elements, including ‘‘all-in-one’’ CRISPR/Cas9 plasmids, but is limited by toxicity as well as poor intracellular release and transfection efficiency in immune cell populations.”
BackgroundInfluentialApplications of CRISPR/Cas9 Technology in Ornamental Plants
Liu, H., Wang, Z., Liu, Y., Wei, Y., Hu, Z., Wu, X., Zheng, C., & Wang, C. (2023) · Plant Molecular Biology Reporter · doi:10.1007/s11105-023-01417-2 · Cited by 13
“The emergence of gene editing tools has greatly facilitated the study of gene function and the improvement of plant traits (Knott and Doudna 2018).”
Progress in understanding Friedreich’s ataxia using human induced pluripotent stem cells
Schreiber, A. M., Misiorek, J. O., Napierala, J. S., & Напиерала, М. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2019.1562334 · Cited by 14
Cooper, V. S., Warren, T. M., Matela, A. M., Handwork, M., & Scarponi, S. (2019) · Evolution Education and Outreach · doi:10.1186/s12052-019-0103-4 · Cited by 13
Singh, D. D., Hawkins, R. D., Lahesmaa, R., & Tripathi, S. K. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.007 · Cited by 13
The analysis of living systems can generate both knowledge and illusions
Jose, A. M. (2020) · eLife · doi:10.7554/elife.56354 · Cited by 14
“Now we can assemble reporter genes with surgical precision using genome-edit- ing approaches such as CRISPR (Knott and Doudna, 2018).”
MethodAdaui, V., Kröber-Boncardo, C., Brinker, C., Zirpel, H., Sellau, J., Arévalo, J., Dujardin, J., & Clos, J. (2020) · Genes · doi:10.3390/genes11101159 · Cited by 19
“Recently, the CRISPR (clustered regularly interspaced short palindromic repeats)–Cas9 (CRISPR-associated protein 9) technology is revolutionizing gene function studies in a wide range of organisms, due to its high efficiency, precision, relative simplicity, and versatility [12].”
BackgroundA Decade of CRISPR Gene Editing in China and Beyond: A Scientometric Landscape
Zhou, W., Yuan, Y., Zhang, Y., & Chen, D. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0148 · Cited by 13
“…and versatile tool for medical research, clinical disease detection and therapies, detection of viral RNA (such as Ebola virus and severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]), breeding of genome-edited crops, livestock, insects, and genetic models, and the study of food microbes.”
Genomic Reporter Constructs to Monitor Pathway-Specific Repair of DNA Double-Strand Breaks
van de Kooij, B., & van Attikum, H. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.809832 · Cited by 13
“This knowledge has driven studies on the fundamentals of DSB-repair for decades, but recently this research interest has grown exponentially due to the development of genome editing approaches using Cas9 and Cas9-like nucleases (Komor et al., 2017; Knott and Doudna, 2018).”
BackgroundThe Prominent Characteristics of the Effective sgRNA for a Precise CRISPR Genome Editing
Mohammadhassan, R., Tutunchi, S., Nasehi, N., Goudarziasl, F., & Mahya, L. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.106711 · Cited by 14
Unlocking Glioblastoma Vulnerabilities with CRISPR-Based Genetic Screening
Fang, Y., Li, X., & Tian, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115702 · Cited by 14
“The development of CRISPR/Cas9 technologies has revolutionized functional screening by significantly improving the robustness and scalability of the screens [10,27].”
BackgroundGenetic engineering drives the breakthrough of pig models in liver disease research
Xu, C., Fang, X., Xu, X., & Wei, X. (2024) · Liver Research · doi:10.1016/j.livres.2024.09.003 · Cited by 12
A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals
Yin, J., Wan, H., Kong, D., Liu, X., Guan, Y., Wu, J., Zhou, Y., Ma, X., Lou, C., Ye, H., et al. (2024) · Cell Systems · doi:10.1016/j.cels.2024.09.002 · Cited by 13
CRISPR/Cas9-directed epigenetic editing in colorectal cancer
Gupta, M. K., Gouda, G., Moazzam‐Jazi, M., Vadde, R., Nagaraju, G. P., & El‐Rayes, B. F. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189338 · Cited by 12
Cheng, Y., Guo, W., Wan, Y., Li, S., Zhou, J., & Wang, J. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03865 · Cited by 12
Liu, W., Wang, L., Ma, F., & Zhang, C. (2025) · Advanced Science · doi:10.1002/advs.202511942 · Cited by 12
Droplet Digital CRISPR for Nucleic Acid Detection
Zhang, Y., Walker, R. S. K., Sunna, A., Barber, T. J., & Li, M. (2026) · Advanced Science · doi:10.1002/advs.202517470 · Cited by 20
The emerging impact of CRISPR and gene editing on global crop improvement
Mansi, M., & Danai, P. (2026) · Transgenic Research · doi:10.1007/s11248-026-00484-x · Cited by 14
“The rapid evolution of CRISPR-based genome editing continues to offer transformative opportunities for agricultural innovation (Knott and Doudna 2018).”
Ciurkot, K., Vonk, B., Gorochowski, T. E., Roubos, J. A., & Verwaal, R. (2019) · Journal of Visualized Experiments · doi:10.3791/59350 · Cited by 18
Long Non-Coding RNAs in Cancer
Rosenlund, I. A., Calin, G. A., Dragomir, M. P., & Knutsen, E. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1581-2 · Cited by 13
CRISPR/Cas9 to Silence Long Non-Coding RNAs
Rosenlund, I. A., Călin, G. A., Dragomir, M. P., & Knutsen, E. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1581-2_12 · Cited by 15
Intelligent host engineering for metabolic flux optimisation in biotechnology
Munro, L. J., & Kell, D. B. (2021) · Biochemical Journal · doi:10.1042/bcj20210535 · Cited by 12
Li, Y., Zhang, L., Yang, H., Xia, Y., Liu, L., Chen, X., & Shen, W. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00059-22 · Cited by 12
“Some of those Cas proteins, especially CRISPR-Cas9, are being harnessed as tools for genome editing (9).”
Genomic landscapes of bacterial transposons and their applications in strain improvement
Wu, S., Tian, P., & Tan, T. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12170-z · Cited by 12
“2020), zinc-finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), and CRISPR-Cas tools (Knott and Doudna 2018; Krogerus et al. 2021).”
BackgroundMethodInfluentialHe, H., Zhou, Y., Chen, B., Zhang, Y., Zhong, X., Xu, L., Guo, B., Yin, C., Zhou, X., Li, Q., et al. (2022) · Talanta · doi:10.1016/j.talanta.2022.123978 · Cited by 12
Anti-CRISPR Discovery: Using Magnets to Find Needles in Haystacks
Forsberg, K. J. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.167952 · Cited by 13
Ahumada-Ayala, M., Aguilar-López, R., González-Stoylov, N., Palacio-Sosa, E., Cervantes-Barragán, D. E., & Fernández‐Hernández, L. (2023) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.22000252 · Cited by 22
“The CRISPR/Cas9 system immunity process includes three phases: adaptation, expression, and interference 18 .”
BackgroundLamothe, R. C., Storlie, M. D., Espinosa, D. A., Rudlaff, R. M., Browne, P. J., Liu, J., Rivas, A., Devoto, A. E., Oki, J., Khoubyari, A., et al. (2023) · The CRISPR Journal · doi:10.1089/crispr.2022.0089 · Cited by 14
Zhang, Y., Zhao, G., Liu, J., Zhang, H., Wang, Y., Luo, Y., Lu, Z.-D., Du, X., Shen, S., Du, J., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101992 · Cited by 12
Song, Y., He, X.-L., Li, Y., Wang, M., Jiang, M., Xu, L., & Yu, X. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341881 · Cited by 12
Zhang, C., Tao, Z., Ye, H., Wang, P., Jiang, M. H., Benard, K., Li, W., & Yan, X. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.740658 · Cited by 12
Zhang, Y., Chen, J., Kong, F., Wang, C., Guo, H., Li, Y., Lü, J., Zhang, J., Wang, J., & Zhou, Y. (2024) · Langmuir · doi:10.1021/acs.langmuir.4c00657 · Cited by 12
Misek, S. A., Fultineer, A., Kalfon, J., Noorbakhsh, J., Boyle, I., Roy, P., Dempster, J. M., Petronio, L., Huang, K. H., Saadat, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48957-z · Cited by 13
“CRISPR is an increasingly important tool in biomedical research 1 and can be leveraged to identify genetic determinants of a range of phenotypes, including cancer cell fi tness 2 .”
Terraforming: synthetic biology’s final frontier
Sleator, R. D., & Smith, N. J. (2019) · Archives of Microbiology · doi:10.1007/s00203-019-01651-x · Cited by 13
“Indeed, recent advances in genetic engineering technologies (Hutchison et al. 2016; Knott and Doudna 2018) mean that it is now faster, cheaper and more technologically practicable to genetically engineer planetary colonists (bioforming) than to physically engineer the planet itself (terraforming).”
BackgroundThe giant titin: how to evaluate its role in cardiomyopathies
Azad, A. J., Poloni, G., Sontayananon, N., Jiang, H., & Gehmlich, K. (2019) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-019-09518-w · Cited by 15
Sakurai, T., Kamiyoshi, A., Takei, N., Watanabe, S., Sato, M., & Shindo, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-46357-8 · Cited by 14
A method for CRISPR/Cas9 mutation of genes in fathead minnow (Pimephales promelas)
Maki, J. A., Cavallin, J. E., Lott, K. G., Saari, T. W., Ankley, G. T., & Villeneuve, D. L. (2020) · Aquatic Toxicology · doi:10.1016/j.aquatox.2020.105464 · Cited by 13
Nanoelectrochemical Study of Molecular Transport through the Nuclear Pore Complex
Amemiya, S. (2021) · The Chemical Record · doi:10.1002/tcr.202000175 · Cited by 12
Rachmatullah, A., Park, S., & Ha, M. (2021) · Cultural Studies of Science Education · doi:10.1007/s11422-021-10066-4 · Cited by 13
“2015), genetically engineered food (Knott and Doudna 2018), and personalized medicine (Alizon and Méthot 2018).”
BackgroundApplications of Genome Editing Technology in Research on Chromosome Aneuploidy Disorders
Akutsu, S. N., Fujita, K., Tomioka, K., Miyamoto, T., & Matsuura, S. (2020) · Cells · doi:10.3390/cells9010239 · Cited by 13
Chen, G. T., Nair, G., Osorio, A. J., Holley, S. M., Ghassemzadeh, K., Zhou, Y., Gonzalez, J., Martin, J. M., Lu, C., Sanjana, N. E., et al. (2026) · Nature Neuroscience · doi:10.1101/2024.03.13.584921 · Cited by 13
Mendez, R., Shaikh, M., Lemke, M. C., Yuan, K., Libby, A. H., Bai, D. L., Ross, M. M., Harris, T. E., & Hsu, K. (2023) · RSC Chemical Biology · doi:10.1039/d3cb00057e · Cited by 11
Wang, M., Schedel, M., & Gelfand, E. W. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.03.016 · Cited by 11
Liu, P., Lin, Y., Zhuo, X., Zeng, J., Chen, B., Zou, Z., Liu, G., Xiong, E., & Yang, R. (2024) · Angewandte Chemie · doi:10.1002/ange.202401486 · Cited by 11
Chen, Z., Sun, Y., Zhu, P., Zhang, L., Yang, J., & Zhang, J. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01990-1 · Cited by 14
“The dCas9-p300 system enhances histone acetylation and transcription at contractile gene promoters (e.g., SM22α and KLF4), whereas dCas9-KRAB recruits repressive complexes to suppress synthetic or inflammatory genes[161].”
Strategies to decipher silent biosynthetic gene clusters in actinomycetes
Murtaza, M., Gupta, P., Choudhary, P., Manzoor, M., Sharma, S., & Jaglan, S. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04590-y · Cited by 11
Mammalian genome writing: Unlocking new length scales for genome engineering
Pinglay, S., Atwater, J. T., Brosh, R., Shendure, J., Maurano, M. T., & Boeke, J. D. (2026) · Cell · doi:10.1016/j.cell.2025.12.034 · Cited by 12
De novo design of potent CRISPR–Cas13 inhibitors
Taveneau, C., Chai, H. X., D’Silva, J., Bamert, R. S., Chen, H., Hayes, B. K., Calvert, R. W., Purcell, J., Curwen, D. J., Munder, F., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-025-02136-3 · Cited by 17
Self-citationNovel Lipid Nanoparticle (LNP) Delivery Systems Enabling the Advancement of RNA Therapeutics
Zhang, H., Han, S., Zhang, X., Ma, J., Jin, L., Wang, Y., Ma, Y., Ma, T., Yu, F., & Song, G. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202505340 · Cited by 18
“These include nuclease-based gene editing tools such as Zinc Finger Nucleases (ZFNs) [220], Transcription Activator-Like Effector Nucleases (TALENs) [221], the CRISPR/Cas [222, 223] system, and safer and more precise Cas9 fusion protein gene editing tools [224].”
Programmable RNA manipulation in living cells
Pei, Y., & Lu, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03252-9 · Cited by 11
Suzuki, T., Tsukumo, Y., Furihata, C., Naito, M., & Kohara, A. (2020) · Genes and Environment · doi:10.1186/s41021-020-0147-2 · Cited by 11
Deep Sequencing Reveals the Comprehensive CRISPR-Cas9 Editing Spectrum in Bombyx mori
Ma, S., Wang, A., Chen, X., Zhang, T., Xing, W., & Xia, Q. (2021) · The CRISPR Journal · doi:10.1089/crispr.2021.0003 · Cited by 16
Lyu, Y., Yin, M., Xi, F., & Hu, X. (2022) · Journal of Data and Information Science · doi:10.2478/jdis-2022-0004 · Cited by 11
“Academic research in this area has made great progress especially since its breakthroughs in 2012 (Knott & Doudna, 2018).”
BackgroundEssential cues of engineered polymeric materials regulating gene transfer pathways
Islam, M. A., Park, T., Firdous, J., Li, H.-S., Jiménez-Pérez, Z. E., Lim, M., Choi, J.-W., Yun, C., & Cho, C. (2022) · Progress in Materials Science · doi:10.1016/j.pmatsci.2022.100961 · Cited by 12
Machine Learning Approaches to Single-Cell Data Integration and Translation
Uhler, C., & Shivashankar, G. V. (2022) · Proceedings of the IEEE · doi:10.1109/jproc.2022.3166132 · Cited by 16
Wang, C., Xia, Q., Zhang, Q., Qu, Y., Su, S., Cheng, J. K. W., Hughes, N. W., & Cong, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.719705 · Cited by 14
“The powerful CRISPR technologies have been widely applied in various biological systems and are greatly changing the field of genome engineering (Cong et al., 2013; Jinek et al., 2013; Hsu et al., 2014; Komor et al., 2017; Knott and Doudna, 2018).”
BackgroundKim, S., Nowakowska, A., Kim, Y. B., & Shin, H. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158217 · Cited by 11
“To test this, we deleted IFNG and/or IFNGR1 genes in the Vero cell line using CRISPR (clustered regularly interspaced short palindromic repeats)-Cas9 (CRISPR-associated protein 9) gene-editing technology, which was developed based on the CRISPR-Cas9 system originally identified as a microbial immune system that serves…”
MethodPolyvalent guide RNAs for CRISPR antivirals
Bagchi, R., Tinker-Kulberg, R. L., Salehin, M., Supakar, T., Chamberlain, S., Ligaba‐Osena, A., & Josephs, E. A. (2022) · iScience · doi:10.1016/j.isci.2022.105333 · Cited by 14
“230 231 Generation of Cas9 target sequences 232 Cas9 DNA targets in Table 4 were generated by either (1) using plasmids containing targets listed in 233 Table S5 or PCR amplification of targets in plasmids using primers listed in Table S9.”
Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update
Bakhtiyari, N., Farajnia, S., Ghasemali, S., Farajnia, S., Pormohammad, A., & Saeidvafa, S. (2024) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265276529231214105423 · Cited by 14
Directed mutagenesis in plants through genome editing using guide RNA library
Dutta, S., Paul, D., Das, A., Kumar, S., Roy, A., Barua, A., & Chinnusamy, V. (2024) · The Nucleus · doi:10.1007/s13237-024-00481-7 · Cited by 12
Rooholamini, Z., Dianat‐Moghadam, H., Esmaeilifallah, M., & Khanahmad, H. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1382996 · Cited by 11
“CRISPR could cause DNA damage and apoptosis as a result of DSBs rather than the targeted gene editing (75).”
BackgroundInfluentialResistance is not futile: bacterial ‘innate’ and CRISPR-Cas ‘adaptive’ immune systems
Fineran, P. C. (2019) · Microbiology · doi:10.1099/mic.0.000802 · Cited by 12
CRISPR-on for activation of endogenous SMARCA4 and TFAP2C expression in bovine embryos
Savy, V., Alberio, V., Canel, N. G., Ratner, L. D., Gismondi, M. I., Ferraris, S., Fernández-Martín, R., Knott, J. G., Bevacqua, R. J., & Salamone, D. (2020) · Reproduction · doi:10.1530/rep-19-0517 · Cited by 12
“2013, Knott & Doudna 2018).”
Tan, R., Du, W., Liu, Y., Cong, X., Bai, M., Jiang, C., Li, Z., Tan, M., Ma, D. K., Huang, Q., et al. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.09.003 · Cited by 11
“CRISPR effectors with nuclease activity, such as Cas9 and Cas12, have been optimized as genome editing tools for precise DNA and RNA editing.(2,3) This system is widely used for gene sequencing, determining compounds’ mode of action,(7,8) and functional gene screening.”
MethodNovel Type V-A CRISPR Effectors Are Active Nucleases with Expanded Targeting Capabilities
Goltsman, D. S. A., Alexander, L. M., Devoto, A. E., Albers, J. B., Liu, J., Butterfield, C. N., Brown, C. T., & Thomas, B. C. (2020) · The CRISPR Journal · doi:10.1089/crispr.2020.0043 · Cited by 14
“CRISPR-Cas systems have emerged in recent years as the gene-editing technology of choice due to their targetability and ease of use.(1) The most commonly used enzymes are the Class 2 Type II SpCas9(2) and the Class 2 Type V-A Cas12a (previously Cpf1) effectors.”
BackgroundLuo, Y., Zhang, L., Teng, Z., & Zheng, T. (2020) · International Journal of Biomathematics · doi:10.1142/s1793524521500194 · Cited by 11
Exploring Endophytes Using “Omics”: An Approach for Sustainable Production of Bioactive Metabolites
Mishra, R. C., Kalra, R., Dwivedi, N., & Goel, M. (2021) · Fungal biology · doi:10.1007/978-3-030-54422-5_15 · Cited by 11
Moreira, J. D., Gopal, D. M., Kotton, D. N., & Fetterman, J. L. (2021) · Genes · doi:10.3390/genes12111668 · Cited by 12
“Scientists now possess the ability to introduce site-specific mutations into the nuclear genome [69,72,73] and even correct mutations to demonstrate the causal role of a specific mutation in the disease process.”
BackgroundTargeted Manipulation of Cellular RNA m6A Methylation at the Single-Base Level
Gao, M., Su, S., Cao, J., Xiang, S., Huang, Y., Shu, X., Ma, J., & Liu, J. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00895 · Cited by 11
Gene Editing-Based Technologies for Beta-hemoglobinopathies Treatment
Rahimmanesh, I., Boshtam, M., Kouhpayeh, S., Khanahmad, H., Dabiri, A., Ahangarzadeh, S., Esmaeili, Y., Bidram, E., Vaseghi, G., Javanmard, S. H., et al. (2022) · Biology · doi:10.3390/biology11060862 · Cited by 16
“The most important advantage is the shorter assembly time and simplicity due to application of artificial sequences which are much easier than protein engineering required in the ZFN and TALEN systems [34].”
BackgroundFuture of Lung Transplantation
Chan, J. C. Y., Chaban, R., Chang, S. H., Angel, L. F., Montgomery, R. A., & Pierson, R. N. (2023) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2022.11.003 · Cited by 13
Ziemann, M., Reimann, V., Liang, Y., Shi, Y., Ma, H., Xie, Y., Li, H., Zhu, T., Lü, X., & Hess, W. R. (2023) · Nature Communications · doi:10.1038/s41467-023-36542-9 · Cited by 13
Imaging of tophi with an extremity-dedicated MRI system.
Paparo, F., Zampogna, G., Fabbro, E., PARODI, M., Andracco, R., Ferrero, G., Garlaschi, G., & Cimmino, M. A. (2011) · PubMed · Cited by 10
High-throughput CRISPR technology: a novel horizon for solid organ transplantation
Li, X., Chen, Z., Ye, W., Yu, J., Zhang, X., Li, Y., Niu, Y., Ran, S., Wang, S., Luo, Z., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295523 · Cited by 11
Zheng, M.-Q., Li, Y., Zhang, L., Li, C., Liu, M., & Tang, H. (2024) · Analytical Methods · doi:10.1039/d4ay00149d · Cited by 10
Precise Gene Knock‐In Tools with Minimized Risk of DSBs: A Trend for Gene Manipulation
Liu, Y. H., Kong, J., Liu, G., Li, Z., & Xiao, Y. (2024) · Advanced Science · doi:10.1002/advs.202401797 · Cited by 13
CRISPR beyond: harnessing compact RNA-guided endonucleases for enhanced genome editing
Wang, F., Ma, S., Zhang, S., Ji, Q., & Hu, C. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2566-8 · Cited by 11
“…battleground between microorganisms and viral invaders, a remarkable defense mechanism has emerged — clustered regularly interspaced short palindromic repeats (CRISPR) and associated proteins (Cas) modules (Hu et al., 2021; Knott and Doudna, 2018; Koonin et al., 2017; Wang and Doudna, 2023).”
Research progress of novel anti-tumor drug formulations
Liu, Y., Guo, Q., Shi, Y., Cui, M., & Jing, F. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1507958 · Cited by 9
Suboktagin, S., Ullah, M. W., Sethupathy, S., Keerio, H. A., Alabbosh, K. F., Khan, K. A., & Zhu, D. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142805 · Cited by 10
Xiao, G., Shi, H., Liu, M., Huang, M., Li, S., Zhou, X., Li, H., & Zhang, G. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.142992 · Cited by 10
Pragya, Kumar, P., Singh, D., Tiwari, S. K., Chouayekh, H., & Singh, B. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.107204 · Cited by 10
Angius, A., Scanu, A. M., Arru, C., Muroni, M. R., Carru, C., Porcu, A., Cossu‐Rocca, P., & Miglio, M. R. D. (2021) · Medicina · doi:10.3390/medicina57111257 · Cited by 15
Genetics Matters: Voyaging from the Past into the Future of Humanity and Sustainability
Cheng, A., Harikrishna, J. A., Redwood, C. S., Lit, L. C., Nath, S. K., & Chua, K. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073976 · Cited by 11
Metadata
- Authors
- Knott, G. J., & Doudna, J. A.
- Affiliations
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Doudna, Jennifer A.
- Venue
- Science
- Published
- 2018-08-31
- Volume
- 361
- Issue
- 6405
- Pages
- 866-869
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6455913
- OpenAlex
- W2888908334
- Cited by
- 1,410
- References
- 76
- Citations by year
- 2026: 92 · 2025: 155 · 2024: 169 · 2023: 177 · 2022: 214 · 2021: 223 · 2020: 205 · 2019: 149 · 2018: 23
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR-Cas, genome editing, transcriptional regulation, CRISPR-Cas diagnostics, agricultural biotechnology
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, RNA, Guide, CRISPR-Cas Systems, Animals, Bacterial Proteins, DNA, Endonucleases, Genetic Engineering, Humans, Plants, RNA, Transcription, Genetic, Molecular Imaging, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.